Funding
Open access funding provided by Paracelsus Medical University Salzburg. This was an investigator-initiated trial. The study was financially supported by Allergan Plc. (grant number IIT-2018–10559). Allergan had no influence on the study design, conduction of the study, or analysis of data, whatsoever.